R RELIABLE BIOPHARMACEUTICAL
Live / Registered — Registered and renewed (as of 15 Jan 2026)
What this means for you
Registered since 10 Oct 1995. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Oct 2025).
Record
- Serial number
- 74443353
- Registration number
- 1926201
- Mark type
- Design + words
- Filed
- 04 Oct 1993
- Published for opposition
- 27 Sept 1994
- Registered
- 10 Oct 1995
- Next maintenance due
- 10 Oct 2025
- Attorney of record
- Jennifer L. Dean
Goods and services
- Class 001 — Chemicals: bulk pharmaceutical chemicals, intermediates, enzymes and biochemicals for use in research, development and manufacturing in the chemical, pharmaceutical, biotechnology and diagnostic fields
Owner
- RELIABLE BIOPHARMACEUTICAL, LLC, RADNOR, PA, US
- RELIABLE BIOPHARMACEUTICAL, LLC, ST. LOUIS, MO, US
- Reliable Biopharmaceutical Corporation, St. Louis, MO, US
- Reliable Biopharmaceutical Corporation, St. Louis, MO, US
- Reliable Biopharmaceutical Corporation, St. Louis, MO, US
Prosecution history
- 15 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 15 Jan 2026 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 15 Jan 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Oct 2025 — TEAS SECTION 8 & 9 RECEIVED
- 10 Oct 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 25 Nov 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 11 Nov 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 27 Dec 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 20 Mar 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Mar 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Jan 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 23 Nov 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 16 Nov 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 07 Jan 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED